Searched for
LATEST CANCER RESEARCH
200 years ago one of Earth's oldest plant chemicals was isolated but researchers now find ways to make new potential medicines with two poisonous flowersScientists have uncovered how two famously poisonous plants produce complex chemicals that could one day contribute to new medicines. Resea...
Time to re-look at a not-so-glamorous part of healthcare ecosystem: 4 diagnostics stocks with upside potential of up to 18%When companies from a sector with a clear growth path get listed, too much money flows into them, sending valuations high. What follows is ...
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsWhen will the US-Iran war end? No one can answer that with any certainty. But whenever it ends, the probability is that volatility will con...
Seoul Semicon’s India plans; Specialty healthcare attracts VCsSouth Korea's Seoul Semiconductor is planning a manufacturing foray in India. This and more in today's ETtech Top 5.
For investors with 1- to 2-year perspective and ability to ignore volatility: 6 stocks with an upside potential of up to 26%The US-Iran war is escalating again, with all that means for crude prices and nervous markets. And halfway across the world, the long AI tr...
Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bnAlembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug...
For investors with an over 2-year perspective: 5 mid- and small-cap stocks with an upside potential of up to 26%This is a market to be selective in, not brave in. The safer way to play a turn in the market is to stay with businesses whose demand does ...
Horoscope Tomorrow, July 14, 2026: Major Career Breakthroughs, Money Gains & Love Surprises Await These Zodiac SignsHoroscope Tomorrow, 14th July 2026: Tomorrow's horoscope highlights a productive day for balancing professional ambitions with emotional we...
Horoscope Tomorrow, 10 July 2026: Major Financial Opportunities, Career Wins & Love Surprises AwaitHoroscope Tomorrow, 10th July 2026, highlights a day of practical progress, career recognition, disciplined financial planning, and stronge...
Own a good business: Volatility, Iran, Trump will all be taken care of. 7 large-cap stocks with upside potential of up to 33%There was a time when many investors said with pride that they owned only blue chips. Today, there are probably only a few of them left. An...
Bryan Johnson's health bombshell: Millionaire who spends $2 million a year to live forever now has an incurable diseaseBryan Johnson, the millionaire known for his anti-ageing pursuits, has revealed a battle with autoimmune gastritis, a condition where his i...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the state of the market these days, it would be wise to be selective. Not only in terms of stocks, but also in terms of sectors. For ...
Scientists believed 'junk DNA' served no purpose but a new study says some of it actually helps stop cancer cells from growingJunk DNA cancer study: Researchers from Arizona State University and an international team have found that so-called junk DNA molecules, kn...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIt is probably time to be bullish as an investor. But remember two things. One: Valuations are still not cheap. Two: Because it is over and...
'Don't die in the meantime': Millionaire Bryan Johnson says some humans may live forever, shares three reasons whyLongevity advocate Bryan Johnson predicts a future where humans might live indefinitely, driven by rapid advancements in biotech and AI. He...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...